Centessa Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,155	1,764	610	243	748	-
Market Cap Growth	83.61%	189.13%	150.68%	-67.44%	-	-
Enterprise Value	3,058	1,418	455	-69	320	-
Last Close Price	21.72	12.71	-	-	-	-
PS Ratio	282.70	-	113.40	-	-	-
PB Ratio	14.06	5.50	3.29	0.87	2.06	-
P/TBV Ratio	14.06	5.50	3.29	0.87	2.06	-
EV/Sales Ratio	270.96	-	84.53	-	-	-
Debt / Equity Ratio	0.39	0.29	0.36	0.21	0.15	1.82
Net Debt / Equity Ratio	-0.42	-0.91	-0.73	-0.96	-1.06	-0.52
Net Debt / EBITDA Ratio	0.60	1.82	1.01	1.54	3.73	0.15
Net Debt / FCF Ratio	0.71	2.56	1.07	1.61	3.81	0.15
Asset Turnover	0.03	-	0.02	-	-	-
Quick Ratio	10.25	9.10	7.51	10.97	24.84	1.18
Current Ratio	10.57	9.25	8.00	11.42	25.52	1.30
Return on Equity (ROE)	-60.62%	-73.93%	-52.79%	-52.24%	-154.41%	-
Return on Assets (ROA)	-25.26%	-26.82%	-26.61%	-24.48%	-27.16%	-
Return on Capital Employed (ROCE)	-51.00%	-38.80%	-53.40%	-51.80%	-23.00%	-337.00%
Earnings Yield	-5.72%	-10.67%	-19.44%	-73.73%	-37.73%	-
FCF Yield	-4.27%	-6.43%	-20.65%	-68.77%	-13.47%	-
Buyback Yield / Dilution	-25.82%	-19.02%	-2.97%	-24.26%	-401.11%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.